Ridgeback Capital is an actively managed private investment company that specializes in both securities trading and long-term private investment, with a particular focus on investing in life science companies. Founded in 2006 by Wayne Holman, MD, Ridgeback Capital and its team seek to support and invest in private and public companies that are developing life-saving and life-changing technologies. Their philosophy revolves around the belief that behind every great advance, there are people who made it happen.

With their long-term private investment capital, separate from their securities trading platform, Ridgeback Capital has the flexibility to support these innovators and fund important changes in the field. Ridgeback Capital's investments primarily center around healthcare advancements. They invest in companies dedicated to creating therapies that have the potential to save lives and bring about meaningful transformations in the healthcare sector.

Dr. Holman, the Founder and CEO of Ridgeback Capital, has been instrumental in providing funding to over 100 biopharma companies for more than 20 years. He is a licensed physician and a graduate of New York University School of Medicine, holding an undergraduate degree in economics from Yale University.

Based in Miami, Dr. Holman resides with his wife, four children, and three dogs. Ridgeback Capital is committed to supporting and investing in the future of healthcare